Molecular Landscape of Prostate Cancer Across Age Groups: Impact on Prognosis and Treatment Outcomes
International Journal of Molecular Sciences · 08.10.2025 · 26 (19) · 9777
DOI: 10.3390/ijms26199777 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.10.2025. Verfasst von Magdalena Julita Orzechowska und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Carcinogenesis, Medical University of Łódź, 90-752 Łódź, Poland. Hauptthemen laut MEDLINE: Prostatic Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Prostate cancer (PC) has long been considered a disease of older men. Still, a significant and concerning rise in diagnoses among younger men has revealed a biologically distinct and more aggressive clinical entity: early-onset prostate cancer (EO-PC). This comprehensive review synthesizes the molecular and clinical evidence to demonstrate that PC is not a single disease, but a collection of distinct entities delineated by patient age. EO-PC is characterized by a strong genetic component, unique fusion events like TMPRSS2-ERG, and a highly plastic phenotype driven by intense Notch signaling and a hybrid epithelial-to-mesenchymal transition. In stark contrast, late-onset prostate cancer (LO-PC) is defined by a higher mutational burden, an epigenetic “field defect” that accumulates with age, and a predominantly immunosuppressive tumor microenvironment. These profound biological differences have significant implications for diagnosis, prognosis, and therapeutic strategies. Traditional prognostic tools, such as the Gleason score, are often insufficient to capture the full spectrum of risk in younger men. The divergent molecular landscapes of EO-PC and LO-PC necessitate a fundamental shift from a standard approach to an age-aware precision medicine framework. This review highlights key therapeutic targets and underscores the critical need for a new paradigm in PC management to improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Carcinogenesis, Medical University of Łódź, 90-752 Łódź, Poland.
ORCID-Profile: Magdalena Julita Orzechowska, Andrzej K Bednarek
Zitieren
APA
Orzechowska, M. J., & Bednarek, A. K. (2025). Molecular Landscape of Prostate Cancer Across Age Groups: Impact on Prognosis and Treatment Outcomes. International Journal of Molecular Sciences, 26(19), 9777. https://doi.org/10.3390/ijms26199777
Vancouver
Orzechowska MJ, Bednarek AK. Molecular Landscape of Prostate Cancer Across Age Groups: Impact on Prognosis and Treatment Outcomes. International Journal of Molecular Sciences. 2025;26(19):9777. doi:10.3390/ijms26199777
BibTeX
@article{Orzechowska2025,
author = {Orzechowska, Magdalena Julita and Bednarek, Andrzej K},
title = {Molecular Landscape of Prostate Cancer Across Age Groups: Impact on Prognosis and Treatment Outcomes},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {19},
pages = {9777},
doi = {10.3390/ijms26199777}
}
EUVIMED